MARIANI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 11.230
NA - Nord America 486
AS - Asia 84
OC - Oceania 2
AF - Africa 1
Totale 11.803
Nazione #
IT - Italia 11.072
US - Stati Uniti d'America 478
SE - Svezia 90
CN - Cina 37
IN - India 19
FI - Finlandia 13
NL - Olanda 12
DE - Germania 11
GB - Regno Unito 10
CA - Canada 7
SG - Singapore 7
ES - Italia 6
FR - Francia 5
HK - Hong Kong 5
IR - Iran 4
TH - Thailandia 4
UA - Ucraina 4
VN - Vietnam 4
GR - Grecia 3
AU - Australia 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
MO - Macao, regione amministrativa speciale della Cina 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 11.803
Città #
Cagliari 11.005
Nyköping 79
Fairfield 72
Chandler 67
Ashburn 42
Houston 31
Wilmington 28
Cambridge 26
Seattle 24
Woodbridge 22
Boardman 20
San Diego 17
New York 16
Shanghai 16
Boston 15
Helsinki 13
Pune 13
Rome 11
Amsterdam 8
Toronto 7
Menlo Park 5
Pamplona 5
Beijing 4
Dearborn 4
Dong Ket 4
Hefei 4
Jacksonville 4
Nanjing 4
Naples 4
London 3
Peristeri 3
Ann Arbor 2
Centro 2
Chicago 2
Delhi 2
Don Mueang 2
Enna 2
Hong Kong 2
Islington 2
Kyjov 2
Livorno 2
Los Angeles 2
Norwalk 2
Paris 2
Romainville 2
San Francisco 2
San Mateo 2
Sydney 2
Xian 2
Zhengzhou 2
Alexandria 1
Amgaon 1
Ankara 1
Assèmini 1
Bergamo 1
Bilbao 1
Cairo 1
Chandigarh 1
Exeter 1
Frattamaggiore 1
Gela 1
Hangzhou 1
Heidelberg 1
Kilburn 1
Lecce 1
Lviv 1
Magelang 1
Milan 1
Naaldwijk 1
Nanchang 1
Nanterre 1
New Bedfont 1
Olbia 1
Port-of-spain 1
Pozzuoli 1
Redwood City 1
Rockville 1
Sambuca di Sicilia 1
Shaoxing 1
Shenzhen 1
Sindelfingen 1
Singapore 1
Somerville 1
South Deerfield 1
Stockholm 1
Tabriz 1
Torino 1
Turin 1
Totale 11.652
Nome #
BRAF-mutant colorectal cancer, a different breed evolving 2.482
Molecular-biology-driven treatment for metastatic colorectal cancer 2.068
New therapeutic targets in pancreatic cancer 1.279
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.236
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 581
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 464
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 462
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 436
Uncovering key targets of success for immunotherapy in pancreatic cancer 400
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 340
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 331
Immune Checkpoint Inhibitors in the Treatment of HCC 327
BRCA-mutant pancreatic ductal adenocarcinoma 321
Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers 296
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 295
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study 282
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 257
Totale 11.857
Categoria #
all - tutte 17.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.341


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201941 0 0 0 0 0 0 0 0 0 0 19 22
2019/2020893 47 19 6 12 254 210 182 35 20 33 23 52
2020/20213.495 69 102 66 1.186 649 407 144 235 102 224 185 126
2021/20221.575 100 73 19 72 69 105 77 140 103 168 290 359
2022/20233.541 359 512 414 287 331 360 189 203 203 219 270 194
2023/20242.238 144 109 101 159 231 470 513 206 141 157 7 0
Totale 11.857